AegirBio AB (publ) reported earnings results for the fourth quarter ended December 31, 2021. For the fourth quarter, the company reported sales was SEK 2.77 million. Net loss was SEK 43 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.636 SEK | +3.25% | +6.00% | -45.64% |
1st Jan change | Capi. | |
---|---|---|
-45.64% | 1.8M | |
+7.01% | 215B | |
+11.01% | 187B | |
+19.20% | 143B | |
+30.79% | 110B | |
+1.48% | 64.68B | |
+13.95% | 52.96B | |
-0.16% | 49.84B | |
-6.20% | 38.32B | |
+0.91% | 35.86B |
- Stock Market
- Equities
- AEGIR Stock
- News AegirBio AB
- AegirBio AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2021